Market Cap 2.58B
Revenue (ttm) 491.73M
Net Income (ttm) 163.89M
EPS (ttm) N/A
PE Ratio 8.43
Forward PE 9.47
Profit Margin 33.33%
Debt to Equity Ratio 0.00
Volume 1,110,500
Avg Vol 1,400,828
Day's Range N/A - N/A
Shares Out 122.39M
Stochastic %K 88%
Beta 0.70
Analysts Strong Sell
Price Target $34.00

Company Profile

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well...

Industry: Biotechnology
Sector: Healthcare
Phone: 305 420 3200
Address:
355 Alhambra Circle, Suite 801, Coral Gables, United States
ADelightfulman
ADelightfulman Aug. 24 at 8:53 PM
$CPRX good call @Dr_Stoxx How about an update? From March 7 2019 stock rec.
0 · Reply
StealthVertex
StealthVertex Aug. 23 at 10:08 AM
$CPRX Catalyst Pharmaceuticals Inc is facing product competition and pipeline development needs
1 · Reply
111ggg
111ggg Aug. 22 at 8:26 PM
$CPRX 52 pennies is darn good for today. Also shows how unloved this sector is.
0 · Reply
RedElephant
RedElephant Aug. 22 at 8:02 PM
$CAPR $SRPT so far down from $120 indicates the Market feels less $ will be going to Elevidys in the future and funds have adjusted, but it's not zero sum! Deramiocel & Elevidys address different aspects of DMD. Elevidys is a one-time gene therapy delivering a micro-dystrophin transgene to skeletal muscle fibers, restoring the missing protein. Deramiocel is a cell therapy whose cardiosphere-derived cells secrete anti-inflammatory, antifibrotic, and immunomodulatory factors to protect muscle (especially the heart) and slow deterioration. Patients could use both: • Elevidys restores dystrophin expression in skeletal muscle, improving muscle strength and function. • Deramiocel targets inflammation and fibrosis in cardiac and potentially skeletal muscle, slowing cardiomyopathy and preserving function over time. Combining them could yield synergistic benefits: durable dystrophin from Elevidys plus ongoing immunomodulation and tissue preservation from Deramiocel. For DMD I'm long $CAPR & $CPRX
3 · Reply
david999957
david999957 Aug. 22 at 5:35 PM
$CPRX This is going a LOT higher. Don't settle for pennies.
0 · Reply
111ggg
111ggg Aug. 22 at 2:12 PM
$CPRX 6 month high for XBI. I THINK THAT IS GOOD
1 · Reply
111ggg
111ggg Aug. 22 at 12:40 PM
$CPRX redundant, but it seems to work. Can we add a few more pennies today?
0 · Reply
ZVRA100
ZVRA100 Aug. 22 at 3:30 AM
0 · Reply
ChromeOnTheWheels
ChromeOnTheWheels Aug. 21 at 8:37 PM
$TALK This was one of the most brutal earnings seasons of the past few years, where even decent performance meant the stock got hammered. Luckily these are all recovering nicely. $CPRX $GDYN $KD
0 · Reply
xbibackto65s
xbibackto65s Aug. 21 at 6:53 PM
$CPRX Buyout target if any pharma co is smart!
0 · Reply
Latest News on CPRX
Top 3 Health Care Stocks You'll Regret Missing This Quarter

Jun 26, 2025, 8:15 AM EDT - 2 months ago

Top 3 Health Care Stocks You'll Regret Missing This Quarter

MBRX


Strong Inflows Make Catalyst Stock an Outlier

Jun 11, 2025, 7:08 AM EDT - 2 months ago

Strong Inflows Make Catalyst Stock an Outlier


Strong Revenue, Drug Performance Lift Catalyst Shares

Mar 26, 2025, 8:12 AM EDT - 5 months ago

Strong Revenue, Drug Performance Lift Catalyst Shares


Catalyst Remains a Big Money Favorite

Feb 7, 2025, 3:56 PM EST - 7 months ago

Catalyst Remains a Big Money Favorite


Catalyst Pharmaceuticals: The Stars Align For Flagship FIRDAPSE

Jan 13, 2025, 8:30 AM EST - 7 months ago

Catalyst Pharmaceuticals: The Stars Align For Flagship FIRDAPSE


Top 3 Health Care Stocks That May Crash In August

Aug 14, 2024, 8:35 AM EDT - 1 year ago

Top 3 Health Care Stocks That May Crash In August

CAH VRNA


Top 3 Health Care Stocks You May Want To Dump This Quarter

Jul 30, 2024, 10:13 AM EDT - 1 year ago

Top 3 Health Care Stocks You May Want To Dump This Quarter

VRDN VRNA


ADelightfulman
ADelightfulman Aug. 24 at 8:53 PM
$CPRX good call @Dr_Stoxx How about an update? From March 7 2019 stock rec.
0 · Reply
StealthVertex
StealthVertex Aug. 23 at 10:08 AM
$CPRX Catalyst Pharmaceuticals Inc is facing product competition and pipeline development needs
1 · Reply
111ggg
111ggg Aug. 22 at 8:26 PM
$CPRX 52 pennies is darn good for today. Also shows how unloved this sector is.
0 · Reply
RedElephant
RedElephant Aug. 22 at 8:02 PM
$CAPR $SRPT so far down from $120 indicates the Market feels less $ will be going to Elevidys in the future and funds have adjusted, but it's not zero sum! Deramiocel & Elevidys address different aspects of DMD. Elevidys is a one-time gene therapy delivering a micro-dystrophin transgene to skeletal muscle fibers, restoring the missing protein. Deramiocel is a cell therapy whose cardiosphere-derived cells secrete anti-inflammatory, antifibrotic, and immunomodulatory factors to protect muscle (especially the heart) and slow deterioration. Patients could use both: • Elevidys restores dystrophin expression in skeletal muscle, improving muscle strength and function. • Deramiocel targets inflammation and fibrosis in cardiac and potentially skeletal muscle, slowing cardiomyopathy and preserving function over time. Combining them could yield synergistic benefits: durable dystrophin from Elevidys plus ongoing immunomodulation and tissue preservation from Deramiocel. For DMD I'm long $CAPR & $CPRX
3 · Reply
david999957
david999957 Aug. 22 at 5:35 PM
$CPRX This is going a LOT higher. Don't settle for pennies.
0 · Reply
111ggg
111ggg Aug. 22 at 2:12 PM
$CPRX 6 month high for XBI. I THINK THAT IS GOOD
1 · Reply
111ggg
111ggg Aug. 22 at 12:40 PM
$CPRX redundant, but it seems to work. Can we add a few more pennies today?
0 · Reply
ZVRA100
ZVRA100 Aug. 22 at 3:30 AM
0 · Reply
ChromeOnTheWheels
ChromeOnTheWheels Aug. 21 at 8:37 PM
$TALK This was one of the most brutal earnings seasons of the past few years, where even decent performance meant the stock got hammered. Luckily these are all recovering nicely. $CPRX $GDYN $KD
0 · Reply
xbibackto65s
xbibackto65s Aug. 21 at 6:53 PM
$CPRX Buyout target if any pharma co is smart!
0 · Reply
xbibackto65s
xbibackto65s Aug. 21 at 4:28 PM
$CPRX will end red like always
0 · Reply
111ggg
111ggg Aug. 21 at 1:35 PM
$CPRX Good start. Up 1 penny. Haha
0 · Reply
111ggg
111ggg Aug. 21 at 1:28 PM
$CPRX Lets go for a few more pennies today. Reminds me of the days when 101 and I talked about the 3 cent days for months.
1 · Reply
JackCampbell
JackCampbell Aug. 20 at 6:31 PM
$CPRX Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Uniphar to manage the distribution of AGAMREE® (vamorolone) in the United Arab Emirates, the Kingdom of Saudi Arabia, Kuwait, Oman and Bahrain, for the treatment of Duchenne muscular dystrophy (DMD) in patients four years of age and older.
0 · Reply
111ggg
111ggg Aug. 20 at 1:57 PM
$CPRX we will try again to capture a few penny gain by end of day.
1 · Reply
DJS777
DJS777 Aug. 19 at 7:48 PM
$VTEX The last 5 days it bounced and rejected several times that $3.90 range and I coming back up showing strength 💪🏽 resistance around or just below $4.20 . A good entry point would be as close to that support as possible for a starter position. Now onto the fundamental key stats. It has profitability, then management effectiveness positive , then growth it has 4% not big but good enough specially been profitable as it's only started been profitable the last 2 quarterly earnings btw, Balance sheet looks good 210 million cash and very little debts in comparison 3.83 million , it has positive operating cash flow also levered free cash flow, Float 55 million nice number not very big or very small 40% held by insiders ownership 45.81% instuitional ownership this is very bullish Also bullish on $CPRX, $RXRX ,
0 · Reply
StillWaiting101
StillWaiting101 Aug. 19 at 7:02 PM
$CPRX don't worry if you are new here, you become use to this, this is the time where they try to convince you to sell every pop because they are just going to drop it later in the day, until you actually do try to time it and sell, then they let it rip
3 · Reply
111ggg
111ggg Aug. 19 at 2:52 PM
$CPRX Timber!!
0 · Reply
ChromeOnTheWheels
ChromeOnTheWheels Aug. 19 at 12:48 AM
$CPRX $REGN $LNTH $SRPT Been adding to all these.
0 · Reply
StillWaiting101
StillWaiting101 Aug. 18 at 6:57 PM
$CPRX if you don't like todays move, then you are in for a bumpy ride, thats the CPRX special today
0 · Reply
111ggg
111ggg Aug. 18 at 3:58 PM
$CPRX xbi and ibb turned red thus cpex will go red.
0 · Reply
bagsOfCash
bagsOfCash Aug. 18 at 2:21 PM
$CPRX good buy here, good bounce off support, macd on daily and weekly look good
2 · Reply